Bausch + Lomb Announces Refinancing of Outstanding Term B Loans

Core Viewpoint - Bausch + Lomb Corporation is refinancing its outstanding term B loans with a new tranche of Replacement Term Loans amounting to $2,802,125,000, aimed at extending maturity and reducing interest rates on existing loans [1]. Financial Summary - The Replacement Term Loans will refinance all outstanding term B loans due in 2031 and 2028, with a maturity date of January 15, 2031, which extends the maturity of the First Incremental Term Loans from September 29, 2028 [1]. - The applicable margin for the Replacement Term Loans is set at 3.75% per annum for loans referenced to term SOFR and 2.75% per annum for loans referenced to the alternate base rate, representing a reduction of 0.50% and 0.25% per annum for the respective loans [1]. Transaction Timeline - The transactions related to the Replacement Term Loans are expected to close in the first quarter of 2026, although there are no guarantees that they will be completed as planned [2]. Company Overview - Bausch + Lomb has a long-standing mission to enhance eye health and improve the quality of life for individuals globally, with a diverse product range including contact lenses, prescription products, and surgical devices [3].